To the Editor: Phillis et al. (1985) have reported that the adenosine deaminase inhibitor erythro-9-(2hydroxy-3-nonyl)adenine (EHNA) and deoxycofor mycin enhance hypoxic hyperemia in the rat brain.
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LETTERS TO THE EDITOR probably not so, since anoxia increased CBF by 55.5 ± 5 and 71.8 ± 11.8% before and after saline injection in Group I, respectively.
(b) Ta king into account that anoxia in the saline treated group increased CBF by 71.8 ± 11.8% (true control value of the drug-treated group) and that the maximum increase of CBF was 90.6 ± 26% after EHNA treatment, whereas deoxycoformycin failed to alter the CBF increasing potency of anoxia, the conclusion that adenosine deaminase inhibitors en hance hypoxic hyperemia does not seem warranted. (d) According to our studies (Dora et aI., 1984; Dora, 1985a) carried out on the brain cortex of chlo ralose anaesthetized cats, topically applied adeno sine deaminase and theophylline or systemic the ophylline treatment did not attenuate the CBF in creasing potency of arterial hypoxia.
A minor point is that some of the data from lit erature and some of their own data were misinter preted by Phillis et al. For example, the authors stated, "The threshold for adenosine's relaxant ef fect on vascular smooth muscle lies at � 1 /l-M . . ." (Phillis et aI., 1985, p 295) . Contrary to this, topi cally (Kovach et aI., 1983) or perivascularly (Wahl and Kuschinsky, 1976) applied adenosine dilatates pial and intracortical arterioles at concentrations of 0.01 /l-M. Actually, 1 /l-M 2-chloroadenosine in creases CBF by �40% (Dora, 1985b) .
Furthermore, although deoxycoformycin failed to alter resting CBF significantly, Phillis et al. (1985) stated that it increased basal flow rate slightly. In this context, I may remark that neither adenosine deaminase nor theophylline alter resting CBF (Emerson and Raymond, 1981; Dora et aI., 1984; Dora, 1985a 
